Please Note: This trial is no longer enrolling new participants
Effect of Rycals (ARM210) on aromatase inhibitor associated muscle weakness
| Protocol No. | IUSCC-0631 | Scope | |
|---|---|---|---|
| Principal Investigator | Tarah Ballinger | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
